3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Multiple Myeloma
15
Myelodysplastic Syndromes
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Hematologic Neoplasms
5
Myeloproliferative Disorders
4
Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neuroblastoma
3
Neoplasm, Residual
3
Leukemia, Myelomonocytic, Juvenile
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Interventions
Gemcitabine
6
Cisplatin
6
pembrolizumab
3
durvalumab
3
Oxaliplatin
3
tivozanib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trametinib
1
tislelizumab
1
olaparib
1
atezolizumab
1
Yttrium-90
1
Stents
1
Radiosurgery
1
Nivolumab
1
Leucovorin
1
Ipilimumab
1
Folfox protocol
1
Fluorouracil
1
Floxuridine
1
Dexamethasone
1
Capecitabine
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
Melphalan
×
90 days
×
Clear all
No trials found.